Carlsmed, Inc. Common Stock CARL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$32.6M-10.0% | -$29.63M-15.1% | -$25.74M-2.8% | -$25.03M-2.0% | -$24.54M-1.2% | ||
| $340K+21.0% | $281K+27.7% | $220K+28.7% | $171K— | —— | ||
| $3.38M+75.5% | $1.93M+55.8% | $1.24M+107% | $599K— | —— | ||
| $4.91M-1.9% | $5.01M-22.7% | $6.48M+30.4% | $4.97M— | —— | ||
| $2.88M+7.2% | $2.69M+51.4% | $1.78M-4.2% | $1.85M— | —— | ||
| $1.36M-41.4% | $2.32M+207% | $757.25K+407% | $149.5K+143% | -$347.25K-217% | ||
| $79K-87.4% | $627K-46.6% | $1.17M+70.4% | $689K— | —— | ||
| $2.79M+19.3% | $2.34M+5.2% | $2.23M— | —— | —— | ||
| —— | -$17K-33.3% | -$12.75K-50.0% | -$8.5K-100% | -$4.25K— | ||
| -$385K-23.0% | -$313K-0.6% | -$311K-1.0% | -$308K— | —— | ||
| -$33.83M-16.7% | -$28.98M-4.0% | -$27.86M-3.3% | -$26.98M— | —— | ||
| $638K-0.6% | $642K+1.9% | $630K+20.5% | $523K— | —— | ||
| —— | $24M+33.3% | $18M+50.0% | $12M+100% | $6M— | ||
| -$25.45M+0.1% | -$25.48M-1,839% | -$1.31M-28.4% | -$1.02M— | —— | ||
| $492K+140% | $205K+7.3% | $191K-1.5% | $194K— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $854K+69.4% | $504K-1.2% | $510K0.0% | $510K+64.5% | $310K-15.8% | ||
| $617K-75.2% | $2.49M-1.4% | $2.53M— | —— | —— | ||
| -$385K-23.0% | -$313K-0.6% | -$311K-1.0% | -$308K— | —— | ||
| $2.79M+19.3% | $2.34M+5.2% | $2.23M— | —— | —— | ||
| $2.08M+13.1% | $1.84M+0.3% | $1.83M+4.3% | $1.76M— | —— | ||
| $188K-8.7% | $206K-5.5% | $218K0.0% | $218K— | —— | ||
| $600K+11.9% | $536K+13.3% | $473K+15.1% | $411K— | —— | ||
| $687K-3.9% | $715K+28.1% | $558K+49.2% | $374K+141% | $155K— | ||
| —— | $24M+33.3% | $18M+50.0% | $12M+100% | $6M— | ||
| —— | $50K+33.3% | $37.5K+50.0% | $25K+100% | $12.5K— | ||
| —— | $5.41M+33.3% | $4.06M+50.0% | $2.71M+100% | $1.35M— | ||
| —— | $93.47M+33.3% | $70.1M+50.0% | $46.73M+100% | $23.37M— | ||
| —— | —— | —— | —— | —— | ||
| —— | $41K+33.3% | $30.75K+50.0% | $20.5K+100% | $10.25K— | ||
| —— | —— | —— | —— | —— | ||
| —— | $0-100% | $105.75K-50.0% | $211.5K-33.3% | $317.25K-25.0% | ||
| $302K-9.9% | $335K-14.1% | $390K+10.5% | $353K+99.4% | $177K+22.9% | ||
| -$385K-23.0% | -$313K-0.6% | -$311K-1.0% | -$308K— | —— | ||
| —— | $69K+33.3% | $51.75K+50.0% | $34.5K+100% | $17.25K— | ||
| —— | $593K+33.3% | $444.75K+50.0% | $296.5K+100% | $148.25K— | ||
| —— | —— | —— | —— | —— | ||
| $42K0.0% | $42K0.0% | $42K— | —— | —— | ||
| —— | $127K+33.3% | $95.25K+50.0% | $63.5K+100% | $31.75K— | ||
| —— | $1.2M+1.8% | $1.18M+1.8% | $1.16M+1.8% | $1.14M+1.9% | ||
| -$34.47M-16.4% | -$29.62M-4.0% | -$28.49M-3.6% | -$27.5M— | —— | ||
| -$34.47M-16.4% | -$29.62M-4.0% | -$28.49M-3.6% | -$27.5M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Carlsmed, Inc. Common Stock generate?
- Carlsmed, Inc. Common Stock (CARL) generated -$33.8M in operating cash flow over the trailing twelve months.
- What is Carlsmed, Inc. Common Stock's free cash flow?
- After $638.0K of capital expenditures, Carlsmed, Inc. Common Stock's free cash flow was -$34.5M over the trailing twelve months.
- Where does Carlsmed, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Carlsmed, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
